You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 5, Issue 2

June 2013 - 21 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (21)

  • Article
  • Open Access
85 Citations
11,104 Views
13 Pages

Effects of Ellagic Acid on Angiogenic Factors in Prostate Cancer Cells

  • Luca Vanella,
  • Claudia Di Giacomo,
  • Rosaria Acquaviva,
  • Ignazio Barbagallo,
  • Giovanni Li Volti,
  • Venera Cardile,
  • Nader G. Abraham and
  • Valeria Sorrenti

19 June 2013

Background: Several natural antioxidants, including ellagic acid (EA), have been reported to have chemotherapeutic activity in vivo and in vitro settings. Cytochrome P450 (CYP) activity and synthesis of both epoxyeicosatrienoic acids (EETs) and 20-h...

  • Article
  • Open Access
219 Citations
22,028 Views
38 Pages

5 June 2013

Colorectal cancer (CRC) develops through a multistage process that results from the progressive accumulation of genetic mutations, and frequently as a result of mutations in the Wnt signaling pathway. However, it has become evident over the past two...

  • Article
  • Open Access
17 Citations
7,923 Views
12 Pages

5 June 2013

In classical Hodgkin’s lymphoma (HL) the malignant mononuclear Hodgkin (H) and multinuclear, diagnostic Reed-Sternberg (RS) cells are rare and generally make up <3% of the total cellular mass of the affected lymph nodes. During recent years, the i...

  • Article
  • Open Access
15 Citations
6,623 Views
14 Pages

Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse

  • Aurelia Nguyen,
  • Christelle Lasthaus,
  • Eric Guerin,
  • Luc Marcellin,
  • Erwan Pencreach,
  • Marie-Pierre Gaub,
  • Dominique Guenot and
  • Natacha Entz-Werle

4 June 2013

Currently, the treatment of pediatric high-grade osteosarcomas systematically includes one topoisomerase IIα inhibitor. This chemotherapy is usually adapted to the response to the neo-adjuvant therapy after surgery. The current and unique marker of c...

  • Review
  • Open Access
27 Citations
12,057 Views
23 Pages

Ras and Rheb Signaling in Survival and Cell Death

  • Anja Ehrkamp,
  • Christian Herrmann,
  • Raphael Stoll and
  • Rolf Heumann

28 May 2013

One of the most obvious hallmarks of cancer is uncontrolled proliferation of cells partly due to independence of growth factor supply. A major component of mitogenic signaling is Ras, a small GTPase. It was the first identified human protooncogene an...

  • Article
  • Open Access
61 Citations
10,053 Views
22 Pages

27 May 2013

Osteopontin and MMP9 are implicated in angiogenesis and cancer progression. The objective of this study is to gain insight into the molecular mechanisms underlying angiogenesis, and to elucidate the role of osteopontin in this process. We report here...

  • Review
  • Open Access
22 Citations
9,297 Views
22 Pages

Immunotherapy and Immune Evasion in Prostate Cancer

  • Archana Thakur,
  • Ulka Vaishampayan and
  • Lawrence G. Lum

24 May 2013

Metastatic prostate cancer remains to this day a terminal disease. Prostatectomy and radiotherapy are effective for organ-confined diseases, but treatment for locally advanced and metastatic cancer remains challenging. Although advanced prostate canc...

  • Review
  • Open Access
207 Citations
16,886 Views
26 Pages

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma

  • Kosei Ando,
  • Marie-Françoise Heymann,
  • Verena Stresing,
  • Kanji Mori,
  • Françoise Rédini and
  • Dominique Heymann

24 May 2013

Osteosarcoma is the most frequent malignant primary bone tumor and a main cause of cancer-related death in children and adolescents. Although long-term survival in localized osteosarcoma has improved to about 60% during the 1960s and 1970s, long-term...

  • Review
  • Open Access
14 Citations
6,768 Views
19 Pages

99mTc-HYNIC-Annexin A5 in Oncology: Evaluating Efficacy of Anti-Cancer Therapies

  • Frédéric L.W.V.J. Schaper and
  • Chris P. Reutelingsperger

15 May 2013

Evaluation of efficacy of anti-cancer therapy is currently performed by anatomical imaging (e.g., MRI, CT). Structural changes, if present, become apparent 1–2 months after start of therapy. Cancer patients thus bear the risk to receive an ineffectiv...

  • Review
  • Open Access
40 Citations
12,289 Views
21 Pages

Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results

  • William W. Tseng,
  • Neeta Somaiah,
  • Alexander J. Lazar,
  • Dina C. Lev and
  • Raphael E. Pollock

10 May 2013

Liposarcoma is one of the most common adult soft tissue sarcomas and consists of three histologic subtypes (well and dedifferentiated, myxoid/round cell, and pleomorphic). Surgery is the mainstay of treatment for localized disease; however for unrese...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694